Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 70518-4616

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 70518-4616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (2e5f04a0 3e2d 494f 837b 18570b6a8546 01)

FDA Label Image

Mm1 (Acamprosate Calcium 333mg 70518 4616 00)

This is a description of Acamprosate Calcium tablets, each containing 333 mg. The packaging includes 50 tablets per box with the NDC number 70518-4616-00. The tablets are round and white in color. The manufacturer is Zydus Pharma USA Inc. The tablets are repackaged by RemedyRepack Inc. in Indiana, PA. The usual dosage instructions can be found in the insert. It is important to keep the medication out of reach of children and store it at a temperature between 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F) as per USP guidelines.*

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Acamprosate Calcium, a delayed-release tablet with a strength of 333 mg. It comes in a white round shape, and each box contains one tablet. The medication is repackaged by RemedyRepack Inc. and should be stored at a temperature between 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F). The manufacturer is Zydus Pharma USA Inc. in Princeton, NJ. It is recommended to keep this medication out of reach of children and to refer to the insert for the usual dosage.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.